|
|
1370: Advancing NK cell immunotherapy in AML |
|
22 January |
11:30
11:45
|
SC Papendal
Room 14
|
|
|
|
1387: Engineering stem cell-derived NK cells with chimeric antigen receptors for immunotherapy o |
|
22 January |
11:45
12:00
|
SC Papendal
Room 14
|
|
|
|
1390: NK cells armed with engineered anti-Her2 antibody enhance cytotoxicity in breast cancer |
|
22 January |
12:00
12:15
|
SC Papendal
Room 14
|
|
|
|
1403: Transfer of stem cell-derived NK cells in rel/ref AML patients: the phase 1 NK4AML study |
|
22 January |
12:15
12:30
|
SC Papendal
Room 14
|
|
